XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Basis of Presentation - Additional Information (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 07, 2023
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
$ / shares
shares
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
shares
Sep. 11, 2025
USD ($)
Sep. 11, 2024
USD ($)
Jul. 06, 2023
shares
Subsidiary, Sale of Stock [Line Items]                      
Stock split ratio, common stock 0.071                    
Common stock, shares authorized (in shares) | shares 107,142,857 107,142,857 107,142,857 107,142,857   107,142,857   107,142,857     1,000,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001 $ 0.0001   $ 0.0001   $ 0.0001      
Accumulated Deficit   $ 259,143,000 $ 259,143,000 $ 259,143,000   $ 259,143,000   $ 255,659,000      
Cash flows from operations           (14,530,000) $ (21,951,000)        
Financed insurance premiums   14,926,000 14,926,000 14,926,000   14,926,000   15,194,000      
Cash and cash equivalents   21,502,000 21,502,000 21,502,000 $ 15,165,000 21,502,000 $ 15,165,000 16,557,000      
WTI Loan Facility | Term Loan                      
Subsidiary, Sale of Stock [Line Items]                      
Term loan facility                   $ 15,000,000  
Financed insurance premiums   4,585,000 4,585,000 4,585,000   4,585,000   0      
WTI Loan Facility | Term Loan | First Tranche Commitment                      
Subsidiary, Sale of Stock [Line Items]                      
Term loan facility                   10,000,000  
Proceeds from long-term borrowings and issuance of redeemable common stock (Note 4)   7,500,000                  
ABL Line of Credit | Line of Credit                      
Subsidiary, Sale of Stock [Line Items]                      
Financed insurance premiums   $ 9,875,000 9,875,000 $ 9,875,000   $ 9,875,000   $ 9,250,000      
ABL Line of Credit | Line of Credit | Revolving Credit Facility                      
Subsidiary, Sale of Stock [Line Items]                      
Maximum borrowing capacity                   $ 15,000,000  
ABL Line of Credit | Line of Credit | Revolving Credit Facility | Forecast                      
Subsidiary, Sale of Stock [Line Items]                      
Maximum borrowing capacity                 $ 20,000,000    
Additional maximum borrowing capacity                 $ 5,000,000    
Revenue Benchmark | Three Largest Customers | Customer Concentration Risk                      
Subsidiary, Sale of Stock [Line Items]                      
Concentration risk percentage       65.00% 52.00% 60.00% 57.00%        
Accounts Receivable | Three Largest Customers | Customer Concentration Risk                      
Subsidiary, Sale of Stock [Line Items]                      
Concentration risk percentage           74.00%   81.00%      
September 2024 Offering                      
Subsidiary, Sale of Stock [Line Items]                      
Consideration received     $ 9,843,000                
Common Stock                      
Subsidiary, Sale of Stock [Line Items]                      
Reduction factor of authorized shares 1.5                    
Preferred stock                      
Subsidiary, Sale of Stock [Line Items]                      
Reduction factor of authorized shares 1.5                    
Preferred stock, shares authorized (in shares) | shares 10,741,071                   100,000,000